论文部分内容阅读
目的考察舒利迭治疗支气管哮喘的疗效。方法对收集的52例患者均给予舒利迭12周治疗,对比治疗前后的临床症状及体征的改善情况,并检测肺功能的变化。结果给予患者舒利迭治疗后,临床控制22例、显效13例、有效11例、无效6例,总有效率达90.38%;与治疗前比较,治疗后患者的肺功能得到显著改善(P<0.05)。结论舒利迭是治疗支气管哮喘的理想药物。
Objective To investigate the efficacy of seretide in the treatment of bronchial asthma. Methods Seventy-two patients were given seretide for 12 weeks. The clinical symptoms and signs were compared before and after treatment. The changes of lung function were detected. Results After treatment with seretide, 22 cases were clinically controlled, 13 cases were markedly effective, 11 cases were effective and 6 cases were ineffective. The total effective rate was 90.38%. Compared with those before treatment, lung function of patients was significantly improved (P < 0.05). Conclusion Seretide is the ideal drug for the treatment of bronchial asthma.